Loading clinical trials...
Loading clinical trials...
An Open-Label, Expanded Access Protocol for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options
Conditions
Interventions
Voxelotor
Locations
18
United States
Alabama Oncology
Birmingham, Alabama, United States
University of South Alabama
Mobile, Alabama, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Augusta University
Augusta, Georgia, United States
Our Lady of the Lake Physician Group
Baton Rouge, Louisiana, United States
University Medical Center New Orleans
New Orleans, Louisiana, United States
Last Updated
July 18, 2023
NCT05170412
NCT06526117
NCT06665997
NCT07431398
NCT07222475
NCT05377372
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions